Uptake and reporting of the Harmonising Outcome Measures for Eczema (HOME) Core Outcome Set in randomized clinical trials for topical anti-inflammatory treatments in Atopic Dermatitis

Clicks: 10
ID: 329358
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #257 of 367 articles by views in the british journal of dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 367 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Inconsistent outcome reporting in randomized controlled trials (RCTs) of topical anti-inflammatory treatments for atopic dermatitis (AD) limits comparability. We evaluated uptake and reporting of Harmonising Outcome Measures for Eczema (HOME) core instruments (EASI, POEM, itch NRS, DLQI) in topical AD RCTs published from 2018 onward. Among 49 eligible RCTs, EASI was most frequently reported (83.7%), followed by DLQI (34.7%), itch NRS (30.6%), and POEM (26.5%). Proper reporting aligned with HOME guidelines was low (15.4-26.7%). Inadequate reporting led to substantial participant-level data waste, reaching up to 67.2% for DLQI. In summary, HOME core outcome uptake and standardized reporting remain limited, particularly for patient-reported outcomes.
Reference Key
openalex_W7213950005 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sai Surabi Thirugnanasampanthar, Renee-Gabrielle Fajardo, Robert Boyle, Yael Leshem, Phylis Spuls, Stephanie Lax, Aaron M Drucker
Journal the british journal of dermatology
Year 2026
DOI
10.1093/bjd/ljag415
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.